Teleflex (NYSE:TFX) Issues Quarterly Earnings Results

by · The Cerbat Gem

Teleflex (NYSE:TFX – Get Free Report) announced its quarterly earnings data on Thursday. The medical technology company reported $1.93 earnings per share for the quarter, missing the consensus estimate of $3.73 by ($1.80), FiscalAI reports. The company had revenue of $569.00 million during the quarter, compared to analyst estimates of $912.57 million. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. Teleflex’s revenue was down 28.5% on a year-over-year basis. During the same period in the prior year, the firm earned $3.89 earnings per share. Teleflex updated its FY 2026 guidance to 6.250-6.550 EPS.

Here are the key takeaways from Teleflex’s conference call:

  • Teleflex signed definitive agreements to sell its Acute Care, Interventional Urology, and OEM businesses for total cash proceeds of $2.03 billion (approximately $1.8 billion after tax), expected to close in H2 2026, and intends to use proceeds to repurchase up to $1 billion of shares and pay down roughly $800 million of debt.
  • 2026 adjusted EPS guidance of $6.25–$6.55 incorporates a full-year drag from an estimated $90 million of stranded costs and excludes positive effects from TSAs/MSAs and planned share repurchases, making 2026 a transition year before expected EPS improvement in 2027.
  • Management approved a restructuring to rightsize the organization and mitigate stranded costs, targeting about $50 million in annual pre-tax savings (substantially completed by mid-2028) with some savings already included in 2026 guidance.
  • The newly defined RemainCo will focus on Vascular, Interventional, and Surgical portfolios and plans to increase R&D to about 8% of sales (vs ~5% historically) to accelerate product innovation and long-term growth.
  • Continuing operations showed pro forma adjusted constant-currency revenue growth of 4.7% in H2 2025 (Interventional +8.1%), 2025 adjusted EPS was $6.98 (+8.7% YoY), and the BIOTRONIK Vascular Intervention acquisition integration is progressing with anticipated salesforce and revenue synergies.

Teleflex Price Performance

Shares of TFX traded up $2.93 during trading hours on Friday, reaching $121.95. The stock had a trading volume of 1,693,141 shares, compared to its average volume of 1,086,067. The stock has a market capitalization of $5.39 billion, a PE ratio of -16.59, a PEG ratio of 1.46 and a beta of 0.92. Teleflex has a 12 month low of $100.18 and a 12 month high of $143.32. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The company’s 50-day moving average is $111.34 and its two-hundred day moving average is $118.72.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th will be issued a dividend of $0.34 per share. The ex-dividend date is Friday, March 6th. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. Teleflex’s dividend payout ratio is -18.50%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Needham & Company LLC upped their price objective on shares of Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research report on Thursday. Wells Fargo & Company boosted their target price on shares of Teleflex from $116.00 to $130.00 and gave the company an “equal weight” rating in a research report on Friday. Truist Financial increased their price target on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research report on Thursday, December 18th. Royal Bank Of Canada boosted their price objective on shares of Teleflex from $115.00 to $125.00 and gave the company a “sector perform” rating in a research report on Friday. Finally, Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Two investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Teleflex presently has an average rating of “Hold” and an average target price of $140.63.

Check Out Our Latest Report on Teleflex

Teleflex News Roundup

Here are the key news stories impacting Teleflex this week:

  • Positive Sentiment: Wells Fargo raised its price target to $130 (from $116) and maintained an “equal weight” rating — a near-term bullish signal that can support buying interest. Read More.
  • Positive Sentiment: Royal Bank of Canada raised its price target to $125 (from $115) with a “sector perform” rating — another analyst lift that helps underpin the rally. Read More.
  • Positive Sentiment: Teleflex’s board declared a quarterly cash dividend of $0.34 per share (record date March 6, payable March 31), which can attract income-seeking investors and provide support. Read More.
  • Positive Sentiment: The company launched a multi‑year restructuring tied to planned divestitures — investors appear to view this as steps to simplify the portfolio, cut costs and potentially unlock value. Read More.
  • Neutral Sentiment: Teleflex published its Q4 presentation and full-year results (material and earnings‑call transcripts are available) — useful for modeling but not a driver by itself. Read More.
  • Negative Sentiment: Q4 results missed materially: EPS $1.93 vs. consensus ~$3.73 and revenue $569M vs. ~$912.6M — revenue fell ~28.5% year-over-year and margins contracted, a clear near-term negative for earnings momentum. Read More.
  • Negative Sentiment: FY‑2026 guidance was significantly reduced: EPS guidance of $6.25–$6.55 and revenue guidance around $2.3B vs. street expectations materially higher (~$15 EPS and ~$3.7B revenue), which is a major downward re‑rating of near-term expectations. Read More.

Institutional Trading of Teleflex

Several hedge funds and other institutional investors have recently made changes to their positions in the company. UMB Bank n.a. raised its holdings in Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after buying an additional 113 shares during the last quarter. Kestra Advisory Services LLC acquired a new position in Teleflex in the 4th quarter valued at approximately $45,000. Danske Bank A S bought a new position in shares of Teleflex during the third quarter valued at $54,000. State of Wyoming bought a new position in shares of Teleflex during the second quarter valued at $111,000. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Teleflex by 108.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock worth $119,000 after purchasing an additional 521 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Teleflex Company Profile

(Get Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

See Also